Transcatheter Mitral Valve Repair with MitraClip for Severe Mitral Regurgitation and Cardiogenic Shock During the COVID-19 Pandemic

Kalyan R. Chitturi; Nadeen N. Faza; Stephen H. Little; Neal S. Kleiman; Michael J. Reardon; Sachin S. Goel

doi:10.1016/j.carrev.2020.05.030

Transcatheter Mitral Valve Repair with MitraClip for Severe Mitral Regurgitation and Cardiogenic Shock During the COVID-19 Pandemic

Kalyan R. Chitturi, Nadeen N. Faza, Stephen H. Little, Neal S. Kleiman, Michael J. Reardon, Sachin S. Goel

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Transcatheter mitral valve repair with MitraClip (Abbott) is largely an elective procedure. The ongoing coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care systems; in many cases elective interventions have been curtailed. Patients with severe mitral regurgitation (MR) and cardiogenic shock are high-risk surgical candidates and at risk of a poor outcome without intervention. The American College of Cardiology (ACC) and the Society of Coronary Angiography and Interventions (SCAI) recently proposed joint guidance on triage of structural heart disease (SHD) interventions during the COVID-19 pandemic. We present two illustrative cases of severe MR and cardiogenic shock that were successfully treated with MitraClip amidst the COVID-19 pandemic with good outcomes at short term follow-up.

Original language	English (US)
Pages (from-to)	950-953
Number of pages	4
Journal	Cardiovascular Revascularization Medicine
Volume	21
Issue number	8
DOIs	https://doi.org/10.1016/j.carrev.2020.05.030
State	Published - Aug 2020

Keywords

COVID-19
Cardiogenic shock
MitraClip
Mitral regurgitation
Severity of Illness Index
Echocardiography
Pandemics
Comorbidity
Heart Valve Prosthesis
Humans
Middle Aged
Mitral Valve/diagnostic imaging
Coronavirus Infections/epidemiology
Male
Shock, Cardiogenic/etiology
Cardiac Catheterization/methods
Heart Valve Prosthesis Implantation/methods
Pneumonia, Viral/epidemiology
Mitral Valve Insufficiency/diagnosis
Betacoronavirus

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.carrev.2020.05.030

Cite this

@article{93357c4e5e0d418e889419ff9089f977,

title = "Transcatheter Mitral Valve Repair with MitraClip for Severe Mitral Regurgitation and Cardiogenic Shock During the COVID-19 Pandemic",

abstract = "Transcatheter mitral valve repair with MitraClip (Abbott) is largely an elective procedure. The ongoing coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care systems; in many cases elective interventions have been curtailed. Patients with severe mitral regurgitation (MR) and cardiogenic shock are high-risk surgical candidates and at risk of a poor outcome without intervention. The American College of Cardiology (ACC) and the Society of Coronary Angiography and Interventions (SCAI) recently proposed joint guidance on triage of structural heart disease (SHD) interventions during the COVID-19 pandemic. We present two illustrative cases of severe MR and cardiogenic shock that were successfully treated with MitraClip amidst the COVID-19 pandemic with good outcomes at short term follow-up.",

keywords = "COVID-19, Cardiogenic shock, MitraClip, Mitral regurgitation, Severity of Illness Index, Echocardiography, Pandemics, Comorbidity, Heart Valve Prosthesis, Humans, Middle Aged, Mitral Valve/diagnostic imaging, Coronavirus Infections/epidemiology, Male, Shock, Cardiogenic/etiology, Cardiac Catheterization/methods, Heart Valve Prosthesis Implantation/methods, Pneumonia, Viral/epidemiology, Mitral Valve Insufficiency/diagnosis, Betacoronavirus",

author = "Chitturi, {Kalyan R.} and Faza, {Nadeen N.} and Little, {Stephen H.} and Kleiman, {Neal S.} and Reardon, {Michael J.} and Goel, {Sachin S.}",

year = "2020",

month = aug,

doi = "10.1016/j.carrev.2020.05.030",

language = "English (US)",

volume = "21",

pages = "950--953",

journal = "Cardiovascular Revascularization Medicine",

issn = "1553-8389",

publisher = "Elsevier",

number = "8",

}

TY - JOUR

T1 - Transcatheter Mitral Valve Repair with MitraClip for Severe Mitral Regurgitation and Cardiogenic Shock During the COVID-19 Pandemic

AU - Chitturi, Kalyan R.

AU - Faza, Nadeen N.

AU - Little, Stephen H.

AU - Kleiman, Neal S.

AU - Reardon, Michael J.

AU - Goel, Sachin S.

PY - 2020/8

Y1 - 2020/8

N2 - Transcatheter mitral valve repair with MitraClip (Abbott) is largely an elective procedure. The ongoing coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care systems; in many cases elective interventions have been curtailed. Patients with severe mitral regurgitation (MR) and cardiogenic shock are high-risk surgical candidates and at risk of a poor outcome without intervention. The American College of Cardiology (ACC) and the Society of Coronary Angiography and Interventions (SCAI) recently proposed joint guidance on triage of structural heart disease (SHD) interventions during the COVID-19 pandemic. We present two illustrative cases of severe MR and cardiogenic shock that were successfully treated with MitraClip amidst the COVID-19 pandemic with good outcomes at short term follow-up.

AB - Transcatheter mitral valve repair with MitraClip (Abbott) is largely an elective procedure. The ongoing coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care systems; in many cases elective interventions have been curtailed. Patients with severe mitral regurgitation (MR) and cardiogenic shock are high-risk surgical candidates and at risk of a poor outcome without intervention. The American College of Cardiology (ACC) and the Society of Coronary Angiography and Interventions (SCAI) recently proposed joint guidance on triage of structural heart disease (SHD) interventions during the COVID-19 pandemic. We present two illustrative cases of severe MR and cardiogenic shock that were successfully treated with MitraClip amidst the COVID-19 pandemic with good outcomes at short term follow-up.

KW - COVID-19

KW - Cardiogenic shock

KW - MitraClip

KW - Mitral regurgitation

KW - Severity of Illness Index

KW - Echocardiography

KW - Pandemics

KW - Comorbidity

KW - Heart Valve Prosthesis

KW - Humans

KW - Middle Aged

KW - Mitral Valve/diagnostic imaging

KW - Coronavirus Infections/epidemiology

KW - Male

KW - Shock, Cardiogenic/etiology

KW - Cardiac Catheterization/methods

KW - Heart Valve Prosthesis Implantation/methods

KW - Pneumonia, Viral/epidemiology

KW - Mitral Valve Insufficiency/diagnosis

KW - Betacoronavirus

UR - http://www.scopus.com/inward/record.url?scp=85085485649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085485649&partnerID=8YFLogxK

U2 - 10.1016/j.carrev.2020.05.030

DO - 10.1016/j.carrev.2020.05.030

M3 - Article

C2 - 32473912

AN - SCOPUS:85085485649

SN - 1553-8389

VL - 21

SP - 950

EP - 953

JO - Cardiovascular Revascularization Medicine

JF - Cardiovascular Revascularization Medicine

IS - 8

ER -

Transcatheter Mitral Valve Repair with MitraClip for Severe Mitral Regurgitation and Cardiogenic Shock During the COVID-19 Pandemic

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this